Form S-6 Morgan Stanley Portfolio
File No. 333-
CIK #1879204
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549-1004
Registration Statement
on
Form S-6
For Registration under the Securities Act of 1933 of Securities of Unit Investment Trusts Registered on Form N-8B-2.
A. |
Exact name of Trust: |
MORGAN STANLEY PORTFOLIOS, SERIES 53 |
|
|
|
B. |
Name of Depositor: |
MORGAN STANLEY SMITH BARNEY LLC |
C. |
Complete address of Depositors principal executive offices: |
|
MORGAN STANLEY SMITH BARNEY LLC
2000 Westchester Avenue
Purchase, NY 10577
D. |
Name and complete address of agents for service: |
MORGAN LEWIS & BOCKIUS LLP |
MORGAN STANLEY SMITH BARNEY LLC |
Attention: Thomas S. Harman, Esq. |
Attention: Michael B. Weiner, Esq. |
1111 Pennsylvania Avenue NW |
2000 Westchester Avenue |
Washington, DC 20004-2541 |
Purchase, New York 10577 |
E. |
Title of securities being registered: Units of fractional undivided beneficial interest |
F. |
Approximate date of proposed sale to the public: |
AS SOON AS PRACTICABLE AFTER THE EFFECTIVE DATE
OF THE REGISTRATION STATEMENT
The registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the Registration Statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a) may determine.
Preliminary Prospectus Dated September 17, 2021
MORGAN STANLEY PORTFOLIOS, SERIES 53
Quality Dividend Strategy, Series 2
The attached final prospectus for a prior series of the Trust is hereby used as a preliminary prospectus for the above stated series. The narrative information and structure of the attached final prospectus will be substantially the same as that of the final prospectus for the current series of the Trust. Information with respect to pricing, the number of units, dates and summary information regarding the characteristics of securities to be deposited in the above stated series is not now available and will be different since each series has a unique portfolio. Accordingly, the information contained herein with regard to the previous series should be considered as being included for informational purposes only.
Information contained herein is subject to completion or amendment. Such units may not be sold nor may an offer to buy be accepted prior to the time the registration statement becomes effective. This prospectus shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the units in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.
(Incorporated herein by reference is the final prospectus from Morgan Stanley Portfolios, Series 50 (Registration No. 333-254902) as filed on June 24, 2021, which shall be used as a preliminary prospectus for the current series of the Trust.)
The Securities and Exchange Commission has not approved or disapproved these securities or passed upon the adequacy of this prospectus. Any representation to the contrary is a criminal offense.
CONTENTS OF REGISTRATION STATEMENT
A. Bonding Arrangements of Depositor:
Morgan Stanley Smith Barney LLC (the Depositor) and its directors, officers and employees are covered by a Financial Institutions Bond with a limit of $200 million. Coverage is provided by ACE Global Markets (a Lloyds of London syndicate) and others.
B. This Registration Statement comprises the following papers and documents:
The Facing Sheet of Form S-6.
The Prospectus.
The Signatures.
The Written Consents of Legal Counsel, Evaluator and Independent Registered Public Accounting Firm (to be supplied by amendment).
The following exhibits:
1.1 Trust Agreement (to be supplied by amendment).
3.1 Opinion and Consent of Counsel as to the legality of securities being registered (to be supplied by amendment).
3.3 Opinion of Counsel as to the Trustee and the Trust (to be supplied by amendment).
4.1 Consent of Evaluator (to be supplied by amendment).
4.2 Consent of Independent Registered Public Accounting Firm (to be supplied by amendment).
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant, Morgan Stanley Portfolios, Series 53, has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized in the City of Purchase and State of New York on the 17th day of September, 2021.
|
MORGAN STANLEY PORTFOLIOS, SERIES 53 | |
|
(Registrant) | |
|
|
|
|
By: |
MORGAN STANLEY SMITH BARNEY LLC |
|
|
(Depositor) |
|
|
|
|
By: |
/s/ MICHAEL B. WEINER |
|
|
Michael B. Weiner |
|
|
Executive Director |
Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed below on September 17, 2021, by the following persons who constitute the principal officers and a majority of the Board of Directors of Morgan Stanley Smith Barney LLC:
SIGNATURE |
|
TITLE |
|
|
|
Andrew Saperstein |
|
Chairman, President and Chief Executive Officer |
|
|
|
Jed Finn |
|
Director |
|
|
|
James Janover |
|
Director |
|
|
|
Benjamin Huneke |
|
Director |
|
|
|
Jacques Adrien |
|
Chief Financial Officer |
|
By: |
/s/ MICHAEL B. WEINER |
|
|
Michael B. Weiner |
|
|
(Attorney-in-fact*) |
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KKR & Co. (KKR) agreed to acquire Immedica Pharma
- KKR and Impilo Announce Strategic Partnership Together With Management in Rare Disease Platform Immedica Pharma
- Sea Ltd. (SE) lifted to overweight at Morgan Stanley as path to profitability becoming clearer
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!